428 related articles for article (PubMed ID: 21671547)
41. The aspirin cardiovascular/gastrointestinal risk calculator--a tool to aid clinicians in practice.
Lanas A; Polo-Tomás M; Casado-Arroyo R
Aliment Pharmacol Ther; 2013 Apr; 37(7):738-48. PubMed ID: 23413984
[TBL] [Abstract][Full Text] [Related]
42. Aspirin for primary prevention of cardiovascular disease in Japan.
Morimoto T; Matsui K
Intern Med; 2007; 46(15):1281. PubMed ID: 17675791
[No Abstract] [Full Text] [Related]
43. Clinical Inquiries: What are the benefits and risks of daily low-dose aspirin for primary prevention of CV events?
Mutter J; Grandy R; Hulkower S; Stigleman S
J Fam Pract; 2018 Apr; 67(4):247-248. PubMed ID: 29614147
[TBL] [Abstract][Full Text] [Related]
44. [Female, young, healthy. ASS does not protect from myocardial infarct].
MMW Fortschr Med; 2005 Mar; 147(12):10. PubMed ID: 15832782
[No Abstract] [Full Text] [Related]
45. Aspirin and women--age matters. Aspirin can help healthy women over age 56 prevent both strokes and heart attacks. For younger women, the hazards of aspirin outweigh the benefits.
Harv Heart Lett; 2005 May; 15(9):1-2. PubMed ID: 15898147
[No Abstract] [Full Text] [Related]
46. An update on aspirin in the primary prevention of cardiovascular disease.
Eidelman RS; Hebert PR; Weisman SM; Hennekens CH
Arch Intern Med; 2003 Sep; 163(17):2006-10. PubMed ID: 14504112
[TBL] [Abstract][Full Text] [Related]
47. Aspirin use in women for primary prevention.
Ferrario MM; Veronesi G
Heart; 2015 Mar; 101(5):335-6. PubMed ID: 25475109
[No Abstract] [Full Text] [Related]
48. Is low-dose aspirin safe for you? If you take daily aspirin, make sure you know why and understand the small but real bleeding risk.
Harv Mens Health Watch; 2012 Oct; 17(3):3. PubMed ID: 23175863
[No Abstract] [Full Text] [Related]
49. Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials.
Kunutsor SK; Seidu S; Khunti K
Diabet Med; 2017 Mar; 34(3):316-327. PubMed ID: 27086572
[TBL] [Abstract][Full Text] [Related]
50. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
51. Potential economic impact of increasing low dose aspirin usage on CVD in the US.
Manson SC; Benedict A; Pan F; Wittrup-Jensen KU; Fendrick AM
Curr Med Res Opin; 2010 Oct; 26(10):2365-73. PubMed ID: 20738228
[TBL] [Abstract][Full Text] [Related]
52. Daily low-dose aspirin: beware of GI bleeding.
Johns Hopkins Med Lett Health After 50; 2012 Mar; 24(1):6. PubMed ID: 22493823
[No Abstract] [Full Text] [Related]
53. The puzzle of aspirin and sex.
Levin RI
N Engl J Med; 2005 Mar; 352(13):1366-8. PubMed ID: 15755763
[No Abstract] [Full Text] [Related]
54. [Platelet-function inhibitors in the secondary prevention of ischemic stroke].
Busse O; Diener HC; Grond M
Dtsch Med Wochenschr; 2006 Nov; 131 Suppl 5():S132-4. PubMed ID: 17089258
[No Abstract] [Full Text] [Related]
55. Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions.
Hennekens CH; Sechenova O; Hollar D; Serebruany VL
J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):170-6. PubMed ID: 17056829
[TBL] [Abstract][Full Text] [Related]
56. An aspirin a day keeps the MI away (for some).
Miser WF
Am Fam Physician; 2002 May; 65(10):2000, 2003. PubMed ID: 12046769
[No Abstract] [Full Text] [Related]
57. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women.
van Kruijsdijk RC; Visseren FL; Ridker PM; Dorresteijn JA; Buring JE; van der Graaf Y; Cook NR
Heart; 2015 Mar; 101(5):369-76. PubMed ID: 25475110
[TBL] [Abstract][Full Text] [Related]
58. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
[No Abstract] [Full Text] [Related]
59. [Acetylsalicylic acid does not prevent cardiovascular disease. Poor scientific support for therapeutic guidelines according to primary prevention studies].
Mooe T
Lakartidningen; 2006 Sep 20-26; 103(38):2732-6. PubMed ID: 17058766
[No Abstract] [Full Text] [Related]
60. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.
Sanmuganathan PS; Ghahramani P; Jackson PR; Wallis EJ; Ramsay LE
Heart; 2001 Mar; 85(3):265-71. PubMed ID: 11179262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
